Search Results
You are looking at 1 - 3 of 3 items for
- Author: Peter J Simons x
- Refine by access: All content x
Institute for Health and Sport (iHeS), Victoria University, Melbourne, Victoria, Australia
Search for other papers by Amanda J Genders in
Google Scholar
PubMed
Search for other papers by Timothy Connor in
Google Scholar
PubMed
Search for other papers by Shona Morrison in
Google Scholar
PubMed
Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
Search for other papers by Simon T Bond in
Google Scholar
PubMed
Search for other papers by Brian G Drew in
Google Scholar
PubMed
Search for other papers by Peter J Meikle in
Google Scholar
PubMed
Search for other papers by Kirsten F Howlett in
Google Scholar
PubMed
Search for other papers by Sean L McGee in
Google Scholar
PubMed
Protein kinase D (PKD) is emerging as an important kinase regulating energy balance and glucose metabolism; however, whether hepatic PKD activity can be targeted to regulate these processes is currently unclear. In this study, hepatic PKD activity was reduced using adeno-associated virus vectors to express a dominant-negative (DN) version of PKD1, which impairs the action of all three PKD isoforms. In chow-fed mice, hepatic DN PKD expression increased whole-body glucose oxidation, but had only mild effects on glucose and insulin tolerance and no effects on glucose homeostasis following fasting and refeeding. However, circulating VLDL cholesterol was reduced under these conditions and was associated with hepatic fatty acid accumulation, but not lipids involved in lipoprotein synthesis. The limited effects on glucose homeostasis in DN PKD mice was despite reduced expression of gluconeogenic genes under both fasted and refed conditions, and enhanced pyruvate tolerance. The requirement for PKD for gluconeogenic capacity was supported by in vitro studies in cultured FAO hepatoma cells expressing DN PKD, which produced less glucose under basal conditions. Although these pathways are increased in obesity, the expression of DN PKD in the liver of mice fed a high-fat diet had no impact on glucose tolerance, insulin action, pyruvate tolerance or plasma VLDL. Together, these data suggest that PKD signalling in the liver regulates metabolic pathways involved in substrate redistribution under conditions of normal nutrient availability, but not under conditions of overnutrition such as in obesity.
Departments of Experimental and Internal Medicine and
Medical Biochemistry, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands
Search for other papers by Peter J Simons in
Google Scholar
PubMed
Departments of Experimental and Internal Medicine and
Medical Biochemistry, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands
Search for other papers by Petra S van den Pangaart in
Google Scholar
PubMed
Departments of Experimental and Internal Medicine and
Medical Biochemistry, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands
Search for other papers by Johannes M F G Aerts in
Google Scholar
PubMed
Departments of Experimental and Internal Medicine and
Medical Biochemistry, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands
Search for other papers by Louis Boon in
Google Scholar
PubMed
Adiponectin and, especially, its oligomeric complex composition have been suggested to be critical in determining insulin sensitivity. Pro-inflammatory cytokines play an important role in the development of insulin resistance in obesity and associated diseases. Therefore, we investigated the effect of long-term exposure of tumour necrosis factor (TNF)-α, interleukin (IL)-6, IL-1β, and interferon (IFN)-γ on total insulin-sensitizing adiponectin secretion and adiponectin complex formation from human adipocytes. In parallel, adipocyte delipidation and leptin production levels were monitored. The present study demonstrates that TNF-α, IL-1β, and IFN-γ dose and time dependently suppressed total adiponectin secretion within 7 days (60, 70, and 35% reduction respectively). IL-6 was also able to reduce (50%) adiponectin production, although only in combination with exogenous soluble IL-6 receptors (sIL-6R). However, the oligomeric distribution (high, middle, and low molecular weight (HMW) complexes) of secreted adiponectin was not altered by any of these cytokines. All studied pro-inflammatory cytokines resulted in delipidation and reduction of lipid-laden adipocyte numbers. Despite this reduction of lipid-laden adipocytes, TNF-α, IL-6/sIL-6R, and IL-1β stimulated leptin release. Our data indicate that (i) long-term pro-inflammatory cytokine exposure downregulates total adiponectin secretion from delipidizing adipocytes and (ii) pro-inflammatory cytokines are not important regulators of adipocyte-derived adiponectin oligomerization. Hence, their individual contribution to low expression of HMW adiponectin found in insulin-resistant conditions seems unlikely. Furthermore, delipidizing adipocytes and preadipocytes are active leptin producers when stimulated by TNF-α, IL-6/sIL-6R, and IL-1β.
Search for other papers by C Tognella in
Google Scholar
PubMed
Search for other papers by U Marti in
Google Scholar
PubMed
Search for other papers by HJ Peter in
Google Scholar
PubMed
Search for other papers by HE Wagner in
Google Scholar
PubMed
Search for other papers by C Glaser in
Google Scholar
PubMed
Search for other papers by J Kampf in
Google Scholar
PubMed
Search for other papers by F Simon in
Google Scholar
PubMed
Search for other papers by HJ Hauselmann in
Google Scholar
PubMed
Search for other papers by M Paulsson in
Google Scholar
PubMed
Search for other papers by C Ruchti in
Google Scholar
PubMed
Search for other papers by ME Burgi-Saville in
Google Scholar
PubMed
Search for other papers by U Burgi in
Google Scholar
PubMed
Search for other papers by H Gerber in
Google Scholar
PubMed
Interactions between follicular epithelial cells and extracellular matrix (ECM) are supposed to play an important role in the development and maintenance of thyroid tissue architecture. In the present study we have therefore investigated the synthesis of ECM components by a feline thyroid cell line which is able to form follicle-like structures in vitro, and also in v-ras-transfected and control-transfected sublines. Transfections were performed by lipofection with pZSR (viral Harvey ras gene; neo) and pSV2-neo (control, neo only) plasmids. We have adapted a semisolid culture system composed exclusively of polymerized alginate and therefore devoid of ECM components. Feline cells embedded in alginate gels as single cells and cultured for up to 90 days formed cell clusters within 10 days. Follicle-like structures were formed in the original cell lines and also in the v-ras- and control-transfected cells. Differences in proliferation rates were observed, the v-ras-transfected cells growing up to two to three times faster than the non-transfected cells. Immunostaining was done using rabbit first antibodies directed against mouse collagen IV, human fibronectin, laminin (tumor Engelbreth-Holm-Swarm laminin), perlecan and other ECM components. For comparison, immunostaining was also performed on cryosections of nodular goiters of six hyperthyroid cats. The cell lines and their transfected clones stained strongly positive for collagen IV and fibronectin, and positively but less strongly for laminin and perlecan. The cat goiter tissue stained positively for collagen IV, laminin, perlecan, and fibronectin, and positive staining for S-laminin (containing the beta2-chain) was seen in blood vessel walls in this tissue. In conclusion, cat cell lines grow three-dimensionally in alginate beads over several weeks, they form follicle-like structures and express the same ECM components as the native cat goiter tissue. Transfection with v-ras does increase proliferation rate, but does not fundamentally alter formation of follicle-like structures and ECM expression. Alginate gel culture is a promising new tool for the study of follicular morphogenesis, polarity, the expression pattern of ECM components and of the interaction between thyrocytes and ECM. It avoids interference caused by gels composed of ECM components.